newsfilter
← Latest News
Business Wire·

Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases

Transaction Creates Fast-Growing Biopharmaceutical Company with Two Commercial Assets and Robust Clinical Pipeline with Multiple Near-term Inflection Points Diversifies Revenue Base with Two Rapidly Growing Brands in Xeris' Gvoke® and Strongbridge'